Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study.
Lukas BaumannDominique L BraunMatthias CavassiniMarcel StoeckleEnos BernasconiPatrick SchmidAlexandra CalmyDavid HaerryCharles BéguelinChristoph A FuxGilles WandelerBernard SurialAndri RauchPublished in: Liver international : official journal of the International Association for the Study of the Liver (2023)
The introduction of DAA therapy was associated with a more than 10-fold reduction in prevalence of replicating HCV infection in PWH, approaching the estimates in the general population. Overall mortality and liver-related events declined substantially in persons living with HIV and hepatitis C.